Sectra adds support for all high-volume digital pathology scanners in bid to improve cancer care

Medical imaging IT giant Sectra announced on Monday that its digital pathology solution now supports all high-volume scanners, a move that’s expected to improve cancer diagnoses and care.

Digital pathology is still an emerging technology with many vendors producing images via proprietary file formats instead of vendor-neutral configurations.

By adding support for two additional file formats, the Linköping, Sweden-based company said providers using its pathology module now have the freedom to choose the scanner and imaging solution most suitable for their practice.

“Imaging solutions are a critical component of healthcare IT infrastructure,” Elin Kindberg, global product manager of pathology at Sectra, said in a statement. “However, without deep integration in surrounding IT systems and support for a wide range of file formats and standards, the true clinical gains will not be realized.

That is why vendor neutrality is so important, and something we strive toward across all our products,” Kindberg added. “Within pathology, we have now taken an important step by pushing vendor neutrality even further.”

Back in March, Sectra received U.S. Food and Drug Administration approval for its digital pathology module. And in June, the Mayo Clinic announced it would begin implementing the pathology solution across its entire enterprise, which includes its Florida and Arizona locations.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.